Skip to main content
. 2021 Jan 2;22(1):409. doi: 10.3390/ijms22010409

Figure 3.

Figure 3

(a) Hematoxylin and eosin (H&E)-stained sections of control and treated mouse liver, EWAT, and RWAT (magnification, 200×). (b) Fatty liver score changes. (c,d) Changes in RWAT (c) and EWAT (d) adipocyte sizes in mice receiving 1 mg/kg/day risperidone treatment and the control group over the course of 56 days. All data for both groups are presented as means ± standard deviation (n = 10). ** p < 0.01, *** p < 0.001.